FDA provides Emergency Use Authorization of 3EO Health COVID-19 Test Developed with Biomedical Advanced Research and Development Authority (BARDA) Support

The 3EO Health COVID-19 Test, from BARDA partner 3EO Health, has become the latest BARDA-supported medical countermeasure (MCM) to receive FDA Emergency Use Authorization (EUA). BARDA and 3EO Health initially partnered in 2022 to develop and obtain FDA EUA for the 3EO Health COVID-19 Test.

Read the full press release from BARDA.